Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment — Stella

Home/Congenital Adrenal Hyperplasia/

View on ClinicalTrials.gov

Recruiting

Back to Congenital Adrenal Hyperplasia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Italy

Federico II University, Naples

Key details

Phase

Post-approval study

Sponsor

Federico II University

Enrollment target

~150 participants

Started

August 2016

Primary completion

December 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.